mGlu2 agonists

Details for Australian Patent Application No. 2010340039 (hide)

Owner Eli Lilly and Company

Inventors Monn, James Allen; Prieto, Lourdes; Taboada Martinez, Lorena; Montero Salgado, Carlos; Shaw, Bruce William

Agent Spruson & Ferguson

Pub. Number AU-A-2010340039

PCT Pub. Number WO2011/084437

Priority 09382290.6 21.12.09 EP; 61/305,239 17.02.10 US

Filing date 15 December 2010

Wipo publication date 14 July 2011

International Classifications

C07D 249/10 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4196 - 1,2,4-Triazoles

A61P 25/00 Drugs for disorders of the nervous system

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/084437 Priority application(s): WO2011/084437

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010340047-A closure for containers of ophthalmic solutions

2010340037-Methods and systems for tracking inventory using an RFID tag tape